These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 14582817

  • 1. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
    Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe MP, Sullivan CL, Day JH.
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
    Raphael GD, Angello JT, Wu MM, Druce HM.
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [Abstract] [Full Text] [Related]

  • 4. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F, Zieglmayer UP, Zieglmayer R, Kavina A, Marschall K, Munzel U, Petzold U.
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [Abstract] [Full Text] [Related]

  • 5. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C.
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL, Gomes P, Welch D, Gopalan G, Srinivasan S.
    Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
    [Abstract] [Full Text] [Related]

  • 7. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE, White MV, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [Abstract] [Full Text] [Related]

  • 9. Desloratadine shows no effect on performance during 6 h at 8,000 ft simulated cabin altitude.
    Valk PJ, Van Roon DB, Simons RM, Rikken G.
    Aviat Space Environ Med; 2004 May; 75(5):433-8. PubMed ID: 15152896
    [Abstract] [Full Text] [Related]

  • 10. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
    Demoly P, Dreyfus I, Dhivert-Donnadieu H, Mesbah K.
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
    [Abstract] [Full Text] [Related]

  • 11. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
    Pradalier A, Neukirch C, Dreyfus I, Devillier P.
    Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE, Schenkel EJ, Mansfield LE, Desloratadine Study Group.
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [Abstract] [Full Text] [Related]

  • 13. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
    Crampton HJ.
    Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
    Grubbe RE, Lumry WR, Anolik R.
    J Investig Allergol Clin Immunol; 2009 Jul; 19(2):117-24. PubMed ID: 19476015
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis.
    Wilken JA, Berkowitz R, Kane R.
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):372-80. PubMed ID: 12392381
    [Abstract] [Full Text] [Related]

  • 17. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
    Bachert C, van Cauwenberge P.
    Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
    Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, van de Heyning P, Loureiro A, Bilastine International Working Group.
    Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
    [Abstract] [Full Text] [Related]

  • 19. Effect of desloratadine on patients with allergic rhinitis and exercise-induced bronchoconstriction: a placebo controlled study.
    Manjra AI, Nel H, Maharaj B.
    J Asthma; 2009 Mar; 46(2):156-9. PubMed ID: 19253122
    [Abstract] [Full Text] [Related]

  • 20. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.
    Meltzer EO, Jalowayski AA, Vogt K, Iezzoni D, Harris AG.
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.